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Characterization of hepatic fatty acids in mice
with reduced liver fat by ultra-short echo time
1H-MRS at 14.1 T in vivo
Ana Francisca Soaresa*, Hongxia Leib,c and Rolf Gruettera,c,d
Alterations in the hepatic lipid content (HLC) and fatty acid composition are associated with disruptions in whole body
metabolism, both in humans and in rodent models, and can be non-invasively assessed by 1H-MRS in vivo. We used
1H-MRS to characterize the hepatic fatty-acyl chains of healthy mice and to follow changes caused by streptozotocin
(STZ) injection. Using STEAM at 14.1 T with an ultra-short TE of 2.8 ms, confounding effects from T2 relaxation and
J-coupling were avoided, allowing for accurate estimations of the contribution of unsaturated (UFA), saturated (SFA),
mono-unsaturated (MUFA) and poly-unsaturated (PUFA) fatty-acyl chains, number of double bonds, PU bonds and
mean chain length. Compared with in vivo 1H-MRS, high resolution NMR performed in vitro in hepatic lipid extracts re-
ported longer fatty-acyl chains (18 versus 15 carbons) with a lower contribution fromUFA (61 ± 1% versus 80 ± 5%) but
a higher number of PU bonds per UFA (1.39 ± 0.03 versus 0.58 ± 0.08), driven by the presence of membrane species in
the extracts. STZ injection caused a decrease of HLC (from 1.7 ± 0.3% to 0.7 ± 0.1%), an increase in the contribution of
SFA (from 21 ± 2% to 45 ± 6%) and a reduction of the mean length (from 15 to 13 carbons) of cytosolic fatty-acyl chains.
In addition, SFAswere also likely to have increased inmembrane lipids of STZ-induceddiabeticmice, alongwith a decrease
of themean chain length. These studies show the applicability of 1H-MRS in vivo tomonitor changes in the composition of
the hepatic fatty-acyl chains in mice even when they exhibit reduced HLC, pointing to the value of this methodology to
evaluate lipid-lowering interventions in the scope of metabolic disorders. Copyright © 2015 John Wiley & Sons, Ltd.
Keywords: mouse liver; fatty acids; streptozotocin (STZ); magnetic resonance spectroscopy (MRS); poly-unsaturated fatty
acids (PUFA)
INTRODUCTION
The liver plays a pivotal role in whole body energy balance, being
actively involved in lipid handling. Accumulation of lipids in the
liver (steatosis) perturbs normal hepatic metabolism (1) and is as-
sociated with insulin resistance, obesity and metabolic syndrome
(2–5). On the other hand, depletion of hepatic lipids may also
occur in cases of metabolic imbalances, such as in animal models
of type 1 diabetes (6,7). Changes in the hepatic lipid content (HLC)
are often accompanied by alterations in the relative contributions
of saturated, mono-unsaturated and poly-unsaturated fatty acids
(SFA, MUFA and PUFA, respectively) to the acyl chains of hepatic
lipids. In humans, steatosis is associated with a depletion of
hepatic PUFA (8), and a diet enriched in PUFA has been shown
to protect against hepatic fat accumulation in both humans (9)
and rodents (10). Alterations in the composition of hepatic and
circulating lipids have also been observed in rodent models of
streptozotocin (STZ)-induced type 1 diabetes (11,12).
Therefore, addressing the hepatic lipids in mice is of interest
for many models of metabolic disorders also present in humans,
as it may bring important insight to mechanisms of disease or
outcome of pharmacological and/or dietary interventions. In this
context, the longitudinal characterization of hepatic fatty acids
may be non-invasively performed by 1H-MRS in vivo since the
different types of proton in these chains give rise to resonances
at speciﬁc chemical shifts in the 1H-MR spectrum (13–15). Point-
resolved spectroscopy (PRESS) and stimulated echo-acquisition
mode (STEAM) are single-scan localization 1H-MRS sequences
widely used to measure hepatic lipids in vivo (16), and both have
been validated against biochemical and histological quantiﬁca-
tions of lipids in hepatic tissue in humans and animal models
(17–22). PRESS has been the preferred technique to study mice
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(18,23–27) as, relative to STEAM, it has a potentially twofold
improved sensitivity, hence allowing for higher signal-to-noise
ratio (SNR). Even so, only a few studies have characterized
hepatic fatty-acyl chains in hepatic lipids in non-steatotic mice
with PRESS by taking advantage of high magnetic ﬁelds (25,27).
Indeed, the reduced sample size and the nature of PRESS, a dou-
ble spin echo sequence with a relatively long TE (in the range of
tens of milliseconds), compromise the detection of less abundant
fatty-acyl protons in the mouse liver. Unlike PRESS, STEAM can
reach a TE as short as 1 ms (28), which, in combination with lower
power requirements, makes STEAMmost advantageous for deter-
mining the hepatic fatty acid composition from a deeper region.
The aim of this study was to quantify the HLC and characterize
the fatty-acyl chains of hepatic lipids (including the relative con-
tributions from SFA, PUFA and MUFA) in healthy mice using an
ultra-short TE STEAM at 14.1 T. These measurements were com-
pared with those performed in liver tissue extracts by high reso-
lution liquid state NMR (HR-NMR). Furthermore, we tested the
power of the method in a model displaying reduced HLC, the
STZ-induced diabetic mouse.
MATERIALS AND METHODS
Phantom studies
A soybean oil-in-water emulsion (Intralipid® 20%) was used to
prepare standards of different lipid content by dilution in distilled
water: 0.2%, 0.5%, 1%, 2.5%, 5%, 7.5%, 10% and 20%. Phantoms
from sunﬂower oil (SO), peanut oil (PO) and respective mixtures
(SO:PO 2:1, 1:1 and 1:2 v/v) were studied to assess the perfor-
mance of the method for different fatty acid compositions. MR
measurements were made with the same imaging and spectros-
copy sequences and parameters as those used for the mouse
experiments in vivo, as described below.
Animal studies
All experiments were approved by the local ethics committee
(Service de la consommation et des affaires vétérinaires, Épalinges,
Switzerland). C57BL/6J mice (Charles Rivers Laboratories,
L’Arbresle, France) were housed in a 12 h light/12 h dark cycle with
free access to water and a standard chow diet (Kliba-Nafag,
Kaiseraugst, Switzerland) and allowed at least 1 week of acclimati-
zation. Twelve mice (4–10 months of age) weighing 23.9–45.0 g
were used in the study to validate HLC quantiﬁcation by 1H-MRS
in vivo. Five mice 4 months of age (25.9 ± 0.7 g) were used to com-
pare the hepatic fatty acid composition estimated from spectra ac-
quired by 1H-MRS in vivo with that estimated from spectra
acquired from the respective liver extracts by HR-NMR in vitro. In
another cohort, ﬁve mice (5months, 32.4 ± 0.9 g) received a single
180 mg/kg intraperitoneal injection of STZ (Sigma-Aldrich, Basel,
Zürich, Switzerland) dissolved in citrate buffer (10 mM, pH 4.5).
Glycemia was measured from tail tip blood with a glucose meter
(Breeze, Bayer, Zürich, Switzerland) and animals were considered
diabetic with values above 15.0 mM. 1H-MRS assessments were
made before STZ injection and 7 and 14 days afterwards, and
HR-NMR was performed in liver extracts for the last time point.
For in vivo MR studies, induction of anesthesia was done with
4% isoﬂurane in an air:oxygenmixture (70:30) for 2 min andmain-
tained with 1–2% isoﬂurane throughout the MR experiment. Mice
were transferred to a home-built holder equipped with circulating
warm water and their body temperature maintained between
36 and 37 °C, as continuously assessed by a rectal probe. The
respiratory rate was maintained between 60 and 90 bpm by
regulating the isoﬂurane level and was continuously monitored
by means of an air pillow through an MR-compatible system
(SA Instruments, Stony Brook, NY, USA) that also delivered neces-
sary triggering signals to the console for respiratory gating. After
the last MR session, mice were immediately euthanized by decap-
itation; the livers were collected and immediately freeze clamped
in liquid nitrogen and stored at 80 °C until further processing.
MR methods
Measurements were made in a horizontal bore 14.1 T–26 cm
magnet interfaced to a Direct Drive console (VnmrJ, Agilent Tech-
nologies, Palo Alto, CA, USA). Mice were scanned in the supine po-
sition with a 1H quadrature surface coil (two 13 mm inner diameter
physically decoupled loops) placed above their abdomens. Auto-
matic shimming to reducemagnetic ﬁeld inhomogeneities was per-
formed with FAST(EST)MAP (29). Multi-slice gradient echo images
were acquired in the sagittal, axial and coronal orientations with a
85° ﬂip angle, a ﬁeld of view of 25 mm × 25 mm, a 128 × 128 data
matrix, minimum TR and minimum TE. From these images a (2 ×
2 × 2) mm3 volume of interest (VOI) was selected and localized
spectroscopy performed using STEAM, as previously described by
Tkáč et al. (28), employing an asymmetric 500 μs 90° RF pulse that
provided a 13.5 kHz bandwidth. At 600 MHz and with gradient
strengths of approximately 100 mT/m, chemical shift displacement
was calculated to be less than ±0.3 mm, not compromising the
localization of the selected VOI within the hepatic parenchyma.
In order to quantify the HLC, water-unsuppressed spectra
consisting of 32–52 scans were acquired with a TE of 8 ms, a
mixing time of 20 ms, a TR of 6.5 s and 4096 complex points.
The TE of 8 ms was used to minimize unwanted gradient-induced
sidebands to the water peak (30), which, although still visible, did
not hamper accurate peak integration of both the water and
visible lipid resonance at 1.3 ppm (Lip1.3). The T2 relaxation times
of water and Lip1.3 were estimated by acquiring spectra with
different TE values (5, 8, 10, 15, 20, 25, 30 and 35 ms) and ﬁtting
the peak area decay with a monoexponential function.
Intrahepatic metabolites were assessed by acquiring additional
spectra from the same VOI with the same STEAM sequence, this
time preceded by VAPOR water suppression and outer volume sat-
uration modules (seven CHESS pulses of 25 000 μs) and including a
15 000 μs gauss pulse during the TM period (28). These spectra
consisted of 16 scans for phantoms and 86–128 scans for mice,
and were acquired with a TE of 2.8 ms, a mixing time of 20 ms, a
TR of 5 s and 2048 complex points. Since water suppression and
outer volume saturation increase the total scan time, compensatory
shortening of the acquisition time was achieved by decreasing the
sampling points to 2048, in order to keep the total running time
within one breathing cycle. To determine the T2 of the fatty-acyl
protons different TE values were used (2.8, 7.2, 14.5, 21.7, 28.9 and
36.2ms) and the signal decay ﬁttedwith amonoexponential function.
The acquisition of one water-unsuppressed spectrum for HLC
quantiﬁcation and one water-suppressed spectrum for fatty acid
characterization was completed within approximately 20 min.
The acquisition time is driven by the number of scans and the
effective TR, which is slightly longer than that programmed in
the sequence due to respiration-triggering.
Tissue extraction and HR-NMR
Livers were lyophilized and pulverized to a ﬁne powder and the lipids
extracted with chloroform:methanol (2:1) following the method
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originally developed by Folch (31). The aqueous phase containing
hydrophilic metabolites was discarded and the chloroform phase
containing the total lipids dried under nitrogen atmosphere to pre-
vent possible oxidation. Lipid samples were dissolved in 500 μl of
d-chloroform and pyrazin was used as internal standard for
quantiﬁcation. Fully relaxed 1H-NMR spectra were acquired in a
DRX-600 spectrometer (Bruker BioSpin, Fällanden, Switzerland)
equipped with a cryoprobe tuned to 1H. Spectra consisted of 16
scans and were obtained with a pulse–acquire sequence using a
pulse delay of 10 s and an acquisition time of 2.5 s. The soybean
oil-in-water emulsion was diluted in deuterated water and its fully
relaxed 1H-NMR spectrum was acquired with a pulse delay of 4 s,
an acquisition time of 2.5 s and suppression of residual water.
1H-MRS data and calculations
Individual spectra were corrected for B0 drift and phase,
summed together and analyzed by line ﬁtting with LCModel
version 6.3-1E (32) using SPTYPE liver-11 with automatic metabo-
lite simulation. Lipid content was estimated from spectra ac-
quired without water suppression as shown in Equation [1], in
which S(0)Lip1.3 is the T2-corrected peak area of Lip1.3 and is
equal to S TEð ÞLip1:3
e
TE=T2 Lip1:3ð Þ
, and S(0)water is the T2-corrected peak area
of water and is equal to S TEð Þwater
e
TE=T2 waterð Þ
.
HLC %ð Þ ¼ S 0ð ÞLip1:3
S 0ð ÞLip1:3þ S 0ð Þwater100: [1]
The chemical composition of the bulk of fatty-acyl chains in
hepatic lipids, hereafter called fatty acid composition, was
estimated fromwater-suppressed spectra acquired in vivo and also
from HR-NMR spectra of liver tissue extracts, following the work of
other authors (14,23,33) by using Equations [2]–[9] (see Fig. 1 for
guidance). Since chemically similar protons are present in distinct
fatty acids, the measured 1H-MRS indices report a theoretical
fatty-acyl chain representing an average of those in hepatic lipids.
Brieﬂy, in Equations [2]–[5], the area of each resonance was
compared with that of the terminal methyl groups (Lip0.9) and
normalized for the number of protons. In the equations, ndb is the
number of double bonds, FA is fatty-acyl chains, PU is the number
of poly-unsaturated bonds and UFA is unsaturated fatty-acyl chains.
For sake of clarity, it should be noted that the saturation index
estimated by Equation [2] depends not only on the saturation level
of the chain but also on the chain length; in Equation [3], the
possible contribution from glyceryl protons (Lip5.2) in the spectra
acquired in vivo was assumed to be negligible; contributions from
non-lipid protons with resonances in the same region as the
fatty-acyl protons (e.g. lactate and alanine at 0.9–1.5 ppm; glutamate,
glutamine, isoleucine at 2.0–2.2 ppm; aspartate at 2.8 ppm) were
assumed to be negligible, given the molarity ratio between fatty-
acyl protons and those from other metabolites (34,35).
Saturation Index ¼ Lip1:33
Lip0:92 [2]
ndb ¼ Lip5:33
Lip0:92 [3]
PU=FA or PUFAð Þ ¼ Lip2:83
Lip0:92 [4]
Figure 1. Identiﬁcation of the different types of proton in the fatty-acyl chains by their speciﬁc resonances in the 1H-MR spectrum. Top, the general
structure of a glyceride where the protons are labeled according to their chemical shift. In triglycerides both R and R′ are additional fatty-acyl chains. In
phospholipids R′ is a phosphate group attached to a simple molecule (e.g. choline in PtdCho). Spectra were obtained by HR-NMR performed in a
soybean oil-in-water emulsion (A) and in lipid samples extracted from the mouse liver (B); and by 1H-MRS with ultra-short TE STEAM performed in a
phantom from soybean oil-in-water emulsion (C) and in the mouse liver (D) in vivo. In addition to glycerides, the soybean oil sample also contained
free glycerol, whose protons are identiﬁed in (A). The inset in (B) depicts speciﬁc resonances from membrane phospholipids visible in the HR-MR
spectrum of the liver extracts. Speciﬁc resonances from poly-unsaturated (PUFA) and di-unsaturated (DUFA) fatty-acyl chains are also identiﬁed. Cho,
choline-containing compounds; Glc/Gly, glucose/glycogen; PE, phosphatidylethanolamine; PtdCho, phosphatidylcholine; SM, sphingomyelin; Tau, taurine.
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UFA %ð Þ ¼ Lip2:13
Lip0:94100: [5]
Fatty-acyl chains can either be saturated (SFA) or unsaturated
(UFA), yielding UFA(%) + SFA(%) = 100 (Equation [6]). Equation
[4] yields the contribution of PUFA in the case where no more
than one Lip2.8 group exists per chain, i.e. the fatty-acyl chains
may contain either zero, one or two double bonds. This is a fair
approximation for hepatic cytosolic lipids (mainly triglycerides),
since the presence of three or more conjugated double bonds
is minimal in hepatic triglycerides in mice fed a standard chow
diet (36). Under such circumstances, MUFA(%) + PUFA(%) +
SFA(%) = 100 (13), and the content of MUFA can be determined
as shown in Equation [7].
SFA ¼ 100 UFA [6]
MUFA ¼ UFA PUFA: [7]
The mean number of poly-unsaturated bonds per UFA was
used as an index of the poly-unsaturation degree and estimated
as the area of the bisallylic protons (Lip2.8) relative to that of the
allylic ones (Lip2.1) using the following equation.
PU=UFA ¼ Lip2:82
Lip2:1
: [8]
The mean chain length (MCL) was estimated as shown in
Equation [9]. One carbon for the terminal methyl group
(Lip0.9), one for the carboxylic group, one for Lip2.3 and ﬁnally
another for Lip1.6 was assumed for each chain, accounting for
the term 4. The number of carbons from the other fatty-acyl
groups varies with chain length and unsaturation degree. Their
areas in the 1H MR spectrum were normalized to the terminal
methyl group with weightings for the carbon to proton ratio.
MCL ¼
1=2 Lip1:3þ Lip2:1þ Lip2:8ð Þ þ Lip5:3&5:2
1=3Lip0:9
þ 4 [9]
Statistics
Numeric data are expressed as mean ± SEM. Statistical difference
was accepted for P < 0.05 as determined with a paired or un-
paired two tailed Student t test, or with a one way ANOVA with
a Newman–Keuls post-test when comparing more than two data
sets. A repeated measurement one way ANOVA with Newman–
Keuls post-test was used to test statistical signiﬁcance of
changes in the measured parameters following STZ injection.
RESULTS
Method validation in phantoms
In order to validate the 1H-MRS method for HLC quantiﬁcation
in vivo, we ﬁrst performed studies in phantoms prepared from
a soybean oil-in-water emulsion, with lipid contents ranging
from 0 to 20%. The lipid content was calculated from spectra
acquired without water suppression (Fig. 2(A)). In these spectra,
the bulk of fatty-acyl methylene protons (Lip1.3) was clearly
identiﬁed and quantiﬁed in all standards, while other resonances
were not as prominent, especially in the low lipid content emul-
sions. The T2 both of the water protons and of Lip1.3 decreased
with increasing lipid content (Table 1). The lipid content as calcu-
lated by 1H-MRS was in excellent correlation (Pearson r = 0.997,
P < 0.0001) with the known lipid content of the diluted standards
(Fig. 2(B)).
Suppression of the water signal in the 1H-MRS acquisitions in
the soybean oil-in-water emulsion resulted in the clear identiﬁca-
tion of all the fatty-acyl proton resonances (Fig. 1(C)). The T2
values of the different types of proton in the 20% oil-in-water
emulsion ranged from 12 to 19 ms (Table 2). A typical spectrum
acquired with 2.8 ms TE STEAM is shown in Fig. 1(C); as can be
appreciated, it closely resembles that obtained from the same
lipid emulsion by HR-NMR in vitro (Fig. 1(A)). The two types of
spectroscopy experiment yielded comparable values for the
Figure 2. Validation of the 1H-MRS quantiﬁcation method on a phan-
tom. (A) 1H-MR spectra acquired with STEAM from (2 × 2 × 2) mm3
volumes in soybean oil emulsions. The water resonance at 4.7 ppm and
the main lipid resonance at 1.3 ppm are identiﬁed. Lipid contents of
0.2, 2.5, 7.5 and 20% are shown as examples. (B) Linear relation between
the 1H-MRS measurements and the known lipid content of the soybean
oil emulsion standards.
Table 1. T2 relaxation times of the water and the methylene
protons of the fatty-acyl chains (Lip1.3) determined by
monoexponential ﬁt of the peak areas with increasing echo
time from the 1H-MR spectra acquired in a lipid emulsion
phantom with STEAM without water suppression. The dif-
ferent standards were prepared by dilution of a 20% soybean
oil emulsion in distilled water
Lipid content
of the standard
emulsion
0% 0.2% 0.5% 1% 2.5% 5% 7.5% 10% 20%
T2 (ms) Water 416 345 345 333 300 236 187 169 152
Lip1.3 – 29 29 27 29 21 23 18 17
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indices used to characterize the fatty-acyl chains (Table 3). We
further assessed the method’s response to changes in the satura-
tion proﬁle in mixtures prepared from SO and PO. The MCL of
the fatty-acyl chains in SO was 17.14 by 1H-MRS and 17.78 by
HR-NMR, similar to that found in PO: 17.70 by 1H-MRS and
17.98 by HR-NMR. These oils had similar UFA contents, as deter-
mined by HR-NMR (SO, 87%; PO, 82%) and 1H-MRS (SO, 85%; PO,
84%), but distinct contributions from PUFA and MUFA (Fig. 3).
When SO:PO mixtures were studied, indices related to the
unsaturation degree reﬂected the relative contributions of each
oil (Fig. 3), supporting the applicability of those indices to detect
changes in fatty acid saturation in vivo. Nevertheless, 1H-MRS
analysis underestimated ndb relative to HR-NMR by, on average,
13%. This discrepancy could be explained by the chemical shift
error between Lip0.9 and Lip5.3, in the presence of the inhomo-
geneous sensitivity of the surface coil used.
MRS of the mouse liver
To place the VOI for in vivo 1H-MRS avoiding major blood vessels,
MR images were acquired from the abdominal region, yielding
well-deﬁned anatomical information (Fig. 4(A)). The line width
at half maximum signal height for the water peak was 69 ± 1 Hz.
Hepatic water T2 relaxation time was 8.0 ± 0.3 ms and that of
Lip1.3 was 19 ± 1ms, as determined from spectra acquired without
water suppression. The HLC determined by 1H-MRS was in
excellent correlation (Pearson r = 0.959, P < 0.0001) with that
determined in vitro in liver tissue extracts (Fig. 3(C)). Hepatic water
content, as measured in a subset of mice, was 70% m/m, which is
equivalent to about 39 M, making the approximation that liver
tissue density is 1000 g/L. For an HLC of 1% in vivo (lower limit of
the observed values), the bulk of fatty-acyl methylene protons
roughly represents 1% of those of water, thus existing in a concen-
tration of about 390 μmol per gram of wet weight or about 1325
μmol per gram of dry weight (experimental conversion factor of
3.4). Since about seven methylene groups exist, on average, in a
fatty-acyl chain (Table 3), the approximate concentration of fatty-
acyl chains in the liver would be about 190 μmol per gram of dry
weight, below the minimum value measured in the liver extracts
(280 μmol per gram of dry weight). The HLC of the studied mice
ranged from 1.1 to 6.9% and was correlated (Pearson r = 0.909,
Table 2. T2 relaxation times (ms) of the fatty-acyl protons
(identiﬁed by their chemical shift, see also Fig. 1) determined
by monoexponential ﬁt of the peak areas with increasing
echo time from the 1H-MR spectra acquired with STEAM
and water suppression. There were no signiﬁcant differences
between the T2 values of the several lipid resonances, either
within the phantom measurements (20% oil-in-water lipid
emulsion) or within the mouse liver measurements (one
way ANOVA with Newman–Keuls post-test)
Soybean emulsion (N = 3) Mouse liver (N = 4–5)
Lip0.9 19 ± 1 19 ± 2
Lip1.3 16 ± 1 23 ± 3
Lip1.6 12 ± 1 17 ± 1
Lip2.1 18 ± 3 18 ± 3
Lip2.3 19 ± 1 21 ± 5
Lip2.8 16 ± 2 17 ± 4
Lip5.3 16 ± 2 23 ± 5
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P< 0.0001) with their body weight (Fig. 3(D)). Mice were studied at
different ages, with older animals (7–10 months) displaying higher
body weight than younger ones (4 months), as expected. The
highest values for body weight and HLC were observed for mice
of 7 months of age, with both younger and older mice showing
lower body weights and HLC.
The group of mice used to investigate the hepatic fatty acid
composition both by 1H-MRS in vivo and HR-MR in vitro showed
an HLC of 1.4 ± 0.1%. Seven fatty-acyl resonances could be iden-
tiﬁed in spectra acquired in vivo, but, compared to the phantom
measurements, Lip4.1 and Lip4.3 from the glyceryl moiety of tri-
glycerides were not clearly discernible (Fig. 1(D)). In addition,
other hepatic resonances were detected and tentative assign-
ments were made for taurine (3.2 and 3.4 ppm), choline con-
taining compounds (3.2 ppm), glucose (3.4 and 3.8 ppm) and
glycogen (3.8 ppm), based on previous 1H-MRS observations
in vivo in humans (37) and HR-MAS measurements made in liver
samples from humans and rodents (38–41). The T2 of the fatty-
acyl resonances ranged from 17 to 23 ms (Table 2), in the same
range as that determined in the phantom. The fatty acid compo-
sition assessed by 1H-MRS in vivo was distinct from that obtained
by HR-NMR in liver extracts in vitro. The percent UFA was higher
in the measurements made in vivo; nevertheless, parameters
related to the unsaturation degree of the fatty-acyl chains (ndb,
PU/FA – poly-unsaturated bonds per fatty-acyl chain – and
PU/UFA – poly-unsaturated bonds per unsaturated fatty acyl
chain) were higher when estimated from the HR-NMR spectra
(Table 3). The MCL was also longer in the latter case, in agree-
ment with higher saturation indices measured from HR-NMR
spectra. Several resonances attributed to phospholipids were
visible in the HR-NMR spectra of liver extracts (Fig. 1(B), inset).
The terminal methyl group of ω-3 PUFA was also clearly visible
in those spectra. This resonance is shifted downﬁeld relative to
the other methyl groups and represented 12 ± 1% of the total
Lip0.9. In addition, in the HR-NMR spectra, PUFAs with three or
more double bonds were resolved from di-unsaturated fatty-acyl
chains by the downﬁeld shift of bis-allylic protons at 2.8 ppm
(Lip2.8).
Effect of STZ on HLC and fatty acid composition
To evaluate the impact of a metabolic stress on the HLC and fatty
acid composition, we studied STZ-induced diabetic mice. The
HLC of these mice determined by 1H-MRS in vivo before STZ in-
jection was 1.7 ± 0.3%, similar to that determined in the cohort
of mice used for the hepatic lipid proﬁle study, but decreased
to 0.6 ± 0.04% (P < 0.05) 7 days post-STZ injection, without fur-
ther changes until the end of the study (0.7 ± 0.1% 14 days post-
STZ, P< 0.05 versus before STZ). The indices used to characterize
hepatic fatty-acyl chains in mice before STZ administration were
not statistically different from those estimated for the cohort of
control mice (Table 3 and Fig. 5). Progressive alterations in the
composition of hepatic fatty acids were detected in the longitu-
dinal follow-up of STZ-induced diabetic mice by 1H-MRS in vivo.
Figure 5 shows the region from 0.6 to 2.6 ppm for representative
liver spectra acquired before STZ administration and 14 days af-
terwards. As can be appreciated, after STZ injection, signals from
methylene (Lip1.3) and allylic (Lip2.1) protons were decreased
relative to the terminal methyl group (Lip0.9). These spectral ob-
servations translated into signiﬁcant alterations of the measured
indices. Shorter fatty-acyl chains were already detected 7 days
post-STZ injection along with a tendency for lower saturation
Figure 3. Saturation index, mean ndb, PUFA and MUFA estimated from spectra acquired by 1H-MRS with ultra-short TE STEAM and by HR-NMR in SO,
PO and respective mixtures. The identity line and Pearson correlation values between methods are also shown for each plot.
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Figure 4. In vivo MRI and 1H-MRS of the mouse liver. (A) Gradient echo anatomical images acquired from the abdominal region of a mouse in the
sagittal, axial and coronal orientations; minimum TR/TE provided good contrast for the identiﬁcation of the blood vessels. A typical VOI of (2 × 2 × 2)
mm3 is also represented in the images. (B) Representative spectrum acquired with STEAM from the depicted volume showing the water resonance
at 4.7 ppm and the resonance from the main lipid component at 1.3 ppm. (C) Linear relation between the HLC determined in mice by 1H-MRS
in vivo and that determined in the liver tissue extracts by HR-NMR. (D) Linear relation between the HLC and the body weight of the mice.
Figure 5. Spectroscopic alterations (grey arrows and dotted lines) in the 0.6–2.6 ppm region observed by 1H-MRS in vivo in the liver of mice 14 days
after the injection of STZ. Temporal evolution of the fatty acid composition after the injection of STZ is shown in the graphs. a P< 0.05 versus before STZ
injection. b P < 0.05 versus 7 days STZ determined with repeated measures one way ANOVA and Newman–Keuls post-test.
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index (P = 0.07). By day 14, the contribution of SFA to hepatic
fatty-acyl chains was more than twice that observed before
STZ injection. Lower unsaturation was ascribed to a reduction
of both hepatic MUFA and PUFA. The MUFA-to-SFA ratio was
2.6 ± 0.4 before STZ injection and decreased to 2.0 ± 0.4, 7 days
after STZ injection (P < 0.05) and further to 0.9 ± 0.2 by day 14
post-STZ (P < 0.01 versus before STZ and P < 0.05 versus 7 days
post-STZ). The PUFA-to-SFA ratio decreased from 1.6 ± 0.4
before STZ injection to 0.3 ± 0.1 by day 7 post-STZ (P< 0.05), with
no further changes by day 14 post-STZ (0.5 ± 0.2, P < 0.05 versus
before STZ).
HR-NMR analyses of liver extracts 14 days post-STZ injection
reported longer chains, higher saturation index and more double
bonds and poly-unsaturated bonds per chain relative to the
matched assessments by 1H-MRS in vivo (Table 3), reproducing
the observations in the control cohort. However, unlike the case
in controls, the UFA-to-SFA ratio was similar in both the in vivo
and in vitro measurements in STZ mice. This is because this ratio
was already unbalanced towards SFA in the fatty-acyl chains
detected in vivo. Compared with ﬁndings in liver extracts from
control mice, in STZ mice HR-NMR reported shorter chains and
saturation indices with a greater contribution from SFA, but at
the same time more PU/UFA (Table 3).
DISCUSSION
We employed 1H-MRS in vivo at 14.1 T to study an 8 μl volume of the
mouse liver, with particular focus on resonances from protons in the
fatty-acyl chains of hepatic lipids. We were able to follow alterations
in the composition of the fatty-acyl chains, even for reduced hepatic
lipid levels, i.e. after the induction of type 1 diabetes by STZ injection.
In addition to the dominating resonances from the fatty-acyl protons,
we also document the presence of other metabolites, notably cho-
line containing compounds, taurine and glucose and/or glycogen
(Fig. 1(D)), similarly to previous observations in human studies in vivo
(37). Since those resonances include contributions from several
molecules, further studies are envisaged in order to unequivocally
identify non-lipid metabolites in the mouse liver by 1H-MRS in vivo.
Estimations of fatty acid composition by 1H-MRS are based on
resonances from protons that can be part of the molecular struc-
ture of different lipid classes, each one including several species
varying in the length and saturation of their hydrocarbon chains.
Analyses by 1H-MRS lack the power to resolve the lipid classes
and species to which the observed fatty-acyl protons belong. A
comprehensive lipid proﬁle may be achieved by sophisticated
analyses using data from mass-spectrometry measurements
made after subjecting biological samples to a chromatography
separation (42–44). While such methods necessarily demand
tissue harvesting, 1H-MRS in vivo has the advantage of allowing
non-invasive assessments and, furthermore, its estimations are
in good correlation with gas chromatography data (45). There-
fore, although reporting a theoretical fatty-acyl chain averaged
across multiple species, 1H-MRS in vivo remains a relevant meth-
odology in the scope of hepatic lipid abnormalities, especially in
humans (15,39), but also in rodent models (23,25,45–47), given
that repeated measurements may be made in longitudinal
studies to assess disease progression and/or treatment outcome.
The most abundant lipid classes in the liver of mice are tri-
glycerides and phospholipids (10,36,48). Phospholipids are impor-
tant components of biological membranes, whereas triglycerides
constitute over 95% of the lipid cytosolic droplets (43). Due to their
reduced mobility, membrane phospholipids are invisible by
1H-MRS in vivo (49). Thus, it is reasonable to assume that fatty-acyl
resonances observed in vivo mainly report chains in mobile cyto-
solic triglycerides, which constitute important metabolic fuels.
Conversely, during the liver extraction procedure, structural lipids
from membranes are released to the organic medium, thus being
detected in subsequent HR-NMR measurements and, as we show
and discuss further, strongly contributing to the spectra acquired
in vitro.
In addition to the biochemical concerns discussed above,
speciﬁc technical aspects should also be addressed. In mouse
liver spectroscopy, in order to avoid contamination from high
caliber blood vessels, abdominal fat or neighboring organs
such as the gallbladder, a careful placement of the voxel con-
ﬁned to the hepatic parenchyma is critical. At high magnetic
ﬁelds, the possibility to achieve ultra-short TE values is highly
beneﬁcial to study microliter volumes (28,50). Therefore, we
used a VOI size of (2 × 2 × 2) mm3, while most studies use
larger volumes to increase the SNR (17,23–25,27), with a con-
comitant higher risk of contamination from extra-hepatic struc-
tures. Quantiﬁcation of HLC and characterization of fatty acids
by 1H-MRS in vivo rely on the comparison of peak areas from
different resonances and particular characteristics of the pro-
tons contributing to each resonance in the living organ need
to be considered. T1 relaxation confounding effects were over-
come by using TR values of 6.5 s (water-unsuppressed spectra)
and 5 s (water-suppressed spectra), which allowed full recovery
of z-magnetization for the water and fatty-acyl protons, respec-
tively. As in other studies (13,25,45,46), T2 relaxation times were
estimated with a monoexponential function, which overlooks
J-coupling effects on the signal decay of the fatty-acyl protons
(16,51,52). Nonetheless, in a study where spectra were acquired
with STEAM from the liver of healthy volunteers (52), account-
ing for J-coupling modulation yielded T2 values comparable
to those obtained from the simpliﬁed monoexponential model,
supporting the accuracy of our T2 estimations. Hepatic water T2
was 8 ms, shorter than that reported for mice at 11.7 (53), 9.4
(27) and 7 T (25). T2 shortening with increasing magnetic ﬁeld
strength has been previously observed for brain metabolites
(54). Given the fast relaxation of the water protons, notably
relative to the methylene ones, T2 corrections were applied for
quantitative estimations of HLC. The T2 values of the fatty-acyl
protons ranged from 17 to 23 ms, also shorter than previous
observations with PRESS at 9.4 T (27) but in the range of the
values observed in another study with PRESS at 7 T (25). With a
2.8 ms TE, T2 differences yield an error below 5% when com-
paring peak areas from fatty-acyl protons, while J-coupling (JAX
of 7 Hz, typical for the fatty-acyl protons) should contribute as lit-
tle as 0.01% to the signal loss according to cos(πTEJAX). Therefore,
corrections for signal losses due to T2 and J-coupling were dis-
pensed as further corroborated by the phantom experiments
(Table 3). The T2 values of the fatty-acyl protons in the soybean
oil-in-water emulsion (12–19 ms) were comparable to those ob-
served in the mouse liver in vivo and shorter than those reported
for pure oils (25,51,52), which is relevant for validation of the
method, and further supports the accuracy of our results in the
mouse liver in vivo. Moreover, changes in the saturation degree
of the fatty-acyl chains could be successfully identiﬁed by
1H-MRS in mixtures prepared from SO (high levels of PUFA)
and PO (high levels of MUFA), demonstrating the applicability
of the method to follow alterations of the hepatic fatty acid com-
position in vivo.
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It was interesting to observe a relatively wide range of HLC in
control mice in our studies: from 1 to 7% (Fig. 3(C)). The upper
limit of the measured range of values is lower than the
10–30% HLC reported for models of steatosis (18,23,24), yet it
is comparable to that found in mice fed a high fructose diet, in-
ducing hepatic lipid accumulation to a value of about 8% (26).
We observed that mice showing abnormally high HLC were
somewhat overweight when compared with the average of
their counterparts, but not necessarily older. In fact, a good cor-
relation was found between the HLC and the body weight of
mice (Fig. 4(D)). Our ﬁndings show that hepatic lipid accumula-
tion to levels similar to those induced by lipogenic diets may
take place even with a standard chow diet in parallel with the
development of obesity, independently of aging-associated
weight gain. It would be of interest to follow up these prelimi-
nary observations in future studies.
Fatty-acyl chains in hepatic triglycerides may originate from
dietary lipids or be synthesized de novo. In our experiments, die-
tary fat derived from soybean oil that is composed mainly of tri-
glycerides from unsaturated 18-carbon fatty acids with up to a
20% contribution from saturated 16- and 18-carbon fatty acids
(55,56), in agreement with the fatty acid composition estimated
in the soybean oil-in-water emulsion (Table 3). On the other
hand, de novo lipogenesis culminates with the synthesis of 16-
carbon saturated palmitoyl-CoA, which can be further elongated
or desaturated by speciﬁc hepatic enzymes. We estimate an MCL
of 15 carbons for cytosolic fatty acids in control mice, similar to
previous ﬁndings using 1H-MRS in vivo (27). Since this value rep-
resents an average of the ensemble of fatty-acyl chains, it is in-
dicative of the presence of both shorter and longer chains.
Chains shorter than 16 carbons necessarily denote the presence
of partially catabolized species in healthy mice. Comparatively,
hepatic fatty-acyl chains in steatotic mice are, on average, longer
than 18 carbons (46,57), in part due to increased anabolic fatty
acid elongation, at least in mice fed a high fat diet (57). On
the other hand, in mice that experienced a reduction of HLC
following the injection of STZ, we observed a reduction of the
MCL, which could reﬂect increased fatty acid catabolism (6).
Regarding the saturation proﬁle, about 80% of the fatty-acyl
chains in the liver of control mice were UFA (with equal
contributions from PUFA and MUFA), in agreement with other
1H-MRS studies in healthy control mice (25,27). We also found
that, on average, hepatic fatty-acyl chains had one double bond
and a saturation index of about 7. However, it is likely that the
ndb reported by 1H-MRS is slightly underestimated, as sug-
gested by the ﬁndings in oil phantoms (Fig. 3). Using the same
indices, Ye et al. (27) report similar values: about 1.2 and about
7, respectively. On the other hand, Ramamonjisoa et al. (25)
found that the mean ndb in hepatic lipids was about 1.7 and
the saturation index about 10. The younger age of the mice
in our study (4 months) and in that of Ye et al. (6 months)
may explain the different ﬁndings relative to the study of
Ramamonjisoa et al., performed in mice about 10 months old.
Taken together, these studies suggest that the composition of
hepatic fatty-acyl chains in mice may exhibit age-related varia-
tions, even in the absence of lipid-modulating interventions,
and, in principle, this evolution could be monitored by 1H-MRS
methods. The aforementioned alterations in HLC and MCL of
STZ-induced diabetic mice were also accompanied by noticeable
changes in fatty acid saturation. Notably, we observed a reduc-
tion of the MUFA-to-SFA ratio, which could be related to the
absence of insulin-stimulated stearoyl-CoA desaturase activity,
synthesizing MUFA from SFA precursors (58,59). On the other
hand, fatty-acyl chains with low unsaturation have also been
observed in high fat diet models that lead to hepatic lipid
accumulation (47). In this case, however, this likely results from
the accumulation of dietary saturated lipids, and obscures
alterations in lipid metabolism that would lead to increased
MUFA due to augmented stearoyl-CoA desaturase activity (57).
Hence, changes in the hepatic fatty acid saturation parameters
determined by 1H-MRS in vivo may be indicative of diverse
metabolic imbalances and should be carefully interpreted with
respect to the phenotype.
We complemented 1H-MRS in vivo with HR-NMR assessments
in liver extracts, which also detected fatty-acyl protons from
membrane lipids, mostly phospholipids (60). In fact, HR-NMR es-
timations of fatty acid composition were strongly driven by the
presence of these species, which can represent over one-half of
the lipids extracted from the liver of mice (10,36). For example,
SFA accounted for ~20% of the hepatic cytosolic chains
(assessed by 1H-MRS in vivo), but had a signiﬁcantly higher con-
tribution (~40%) in the liver extracts. Assuming that 50% of the
lipids in the extracts derive from membranes (36) and that half
of these are saturated (61), 25% of the fatty-acyl chains in total
lipids would derive from membrane SFA and 10% from cytosolic
SFA. Hence, in total, SFA would contribute to 35% of the fatty-
acyl chains in the liver extracts, in good agreement with our
estimations by HR-NMR. Relative to 1H-MRS in vivo, HR-NMR
estimations reported higher PU/UFA and longer MCL. These
differences further demonstrate the presence of membrane
lipids, which, compared to cytosolic triglycerides, are composed
of longer fatty-acyl chains with a higher degree of poly-
unsaturation (62,63). Notably, PUFAs with three or more methy-
lene interrupted double bonds were identiﬁed in liver extracts
by the downﬁeld shift of Lip2.8 resonance. These same trends
were reported by other authors when adipose tissue lipids were
assessed in the extracted tissue by HR-NMR relative to 1H-MRS
measurements in vivo (64). Phosphatidylcholines (PtdCho)
account for at least one-half of membrane phospholipids, and
the second most abundant class is that of phosphatidylethanol-
amines (36,65). It can be assumed that the singlet at 3.32 ppm in
the HR-NMR spectra is almost exclusively due to PtdCho, since
levels of sphingomyelin, another choline-containing membrane
lipid, are comparatively very small in the liver (48,65–67). This
approximation yields that ~30%† of the fatty-acyl chains can
be ascribed to PtdCho in total hepatic lipids of control mice.
This contribution would be only about 13% for the overweight
mice in our study, in line with a higher contribution from cyto-
solic lipids in this case, as supported by higher HLC detected by
1H-MRS in vivo. On the other hand, the contribution of PtdCho
to the fatty-acyl chains in the liver extracts from STZ-induced
diabetic mice would be about 32% and not higher than that
of control mice, as would have been expected due to a
zreduced contribution from cytosolic lipids (lower HLC by
1H-MRS in vivo). This ﬁnding may reﬂect alterations in hepatic
membrane lipids in these mice. Indeed, in rats, STZ administra-
tion has been shown to cause a depletion of all phospholipid
classes (68).
†PtdCho contains three methyl groups in the choline residue and two termi-
nal methyl groups from the fatty-acyl chains; its contribution to the total fatty
acids in the extracts can be estimated as PtdCho %ð Þ ¼ PtdChoLip0:9  23100 , in
which PtdCho is the area of the peak at 3.32 ppm.
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In addition to possible alterations in PtCho levels, we observed
signiﬁcant changes in the fatty acid composition of total lipids in
livers from STZ-induce diabetic mice, relative to control mice.
Namely, we detected shorter fatty-acyl chains and a higher con-
tribution from SFA, similarly to the ﬁndings for the cytosolic
fatty-acyl chains in the 1H-MRS studies in vivo, and suggesting
concomitant alterations in the fatty acids from membrane lipids.
Concordant with our ﬁndings, it has been shown that the contri-
bution of SFA to liver phospholipids is increased in STZ-induced
diabetes, supported by higher abundance of 16:0 chains (11,69).
We also found the poly-unsaturation degree of the fatty-acyl
chains in total lipids to be higher in livers from STZ mice when
compared with controls. This could potentially be explained by
the reduced contribution of cytosolic lipids in STZ mice with a
concomitant increase in the relative abundance of PUFA from
membrane species. In addition, higher PU/UFA could reﬂect al-
terations in the fatty acid proﬁle of membrane lipids. Imbalances
in PUFA in STZ-induced diabetes have previously been reported
in liver phospholipids (11,69). Membrane phospholipids are im-
portant sources of precursors further metabolized in microsomes
to bioactive compounds. For example, eicosanoids derived from
arachidonic acid (20:4n-6) or docosahexaenoic acid (22:6n-3)
have pro- and anti-inﬂammatory properties, respectively, and
are able to regulate hepatic gene expression, including enzymes
involved in lipid metabolism, which is relevant for the pathology
of diabetes (11). Detailed insight into membrane species would
require further analytical processing of hepatic lipid samples.
While the scope of this study was to investigate alterations by
1H-MRS in vivo under reduced HLC, a comprehensive overview
of alterations in metabolic and regulatory lipid species would
beneﬁt from complementary lipidomics analyses and measure-
ments of metabolic pathways.
CONCLUSION
We conclude that 1H-MRS with an ultra-short TE STEAM provides
an important insight into the composition of the hepatic fatty-
acyl chains inmice in vivo, evenwhen they experience a reduction
of their HLC. By combining data from in vivo and in vitromeasure-
ments we demonstrate that both the cytosolic triglycerides and
membrane phospholipids from the livers of STZ-induced diabetic
mice are enriched with shorter, SFA chains. Despite inherent ana-
lytical limitations, 1H-MRS in vivo is a valuable method to follow
modulation of hepatic fatty acids in the context of lipid-lowering
interventions.
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